ArticleInvestigational new drugs2021

Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.

Shivaani Kummar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.